Text this: Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

  _____    _    _      _____     ___     __   __  
 /  ___|| | || | ||   / ___//   / _ \\   \ \\/ // 
| // __   | || | ||   \___ \\  / //\ \\   \   //  
| \\_\ || | \\_/ ||   /    // |  ___  ||  / . \\  
 \____//   \____//   /____//  |_||  |_|| /_//\_\\ 
  `---`     `---`   `-----`   `-`   `-`  `-`  --`